68 -- Biological Product Manufacturing

NAICS Code:325414. The Federal Bureau of Prisons (BOP) intends to award a sole source contract action to Roche Pharmaceuticals, Inc (Roche) of Middletown, New Jersey for an estimated quantity of 31,500 bottles of TAMIFLU (Oseltamivir Phosphate). TAMIFLU (Oseltamivir Phosphate) is a drug used to treat infections caused by two of the most common flu viruses. Roche is the only manufacturer of TAMIFLU and a generic form of TAMIFLU is not yet available. This is a sole source synopsis published for information purposes only. Solicitation documents are available upon request. This proposed contract action is for a procurement for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1. This notice of intent is not a request for competitive quotations; however, the government will consider all quotations/responses received within eleven (11) days of the issuance of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Interested persons may identify their interest and capability to respond to the requirement. Any information shall be clearly marked with RFQ 100-0007-06 and must be received on or before September 5, 2006, NLT 2:00pm Eastern Standard Time. Any information not received by this date/time and at the location specified in this notice will not be considered. The Point of Contact for all information regarding this acquisition is David Porter, Contract Specialist or Delfina St Clair, Contract Specialist, who can be reached at the following phone number and address: (202) 307-0954, 320 First Street, NW, Room 500-6, Washington, DC 20534.